Shenzhen Neptunus Interlong Bio-technique Company Limited reported earnings results for the third quarter and nine months ended September 30, 2021. For the third quarter, the company reported sales was CNY 205.58 million compared to CNY 300.14 million a year ago. Net income was CNY 5.56 million compared to CNY 10.26 million a year ago. Basic earnings per share from continuing operations was CNY 0.0033 compared to CNY 0.0061 a year ago.
For the nine months, sales was CNY 596.78 million compared to CNY 759.69 million a year ago. Net income was CNY 25.21 million compared to CNY 28.51 million a year ago. Basic earnings per share from continuing operations was CNY 0.015 compared to CNY 0.017 a year ago.